Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metastatic spinal cord compression by solid tumors.

Kristin Gabriel1, David Schiff

  • 1Virginia Commonwealth University Medical Center, Department of Neurology, Richmond, Virginia, USA.

Seminars in Neurology
|January 8, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery and therapeutic delivery of microRNAs targeting deregulated glioblastoma pathways inhibits tumor growth in mice.

The Journal of clinical investigation·2026
Same author

Microenvironment T-Type calcium channels regulate neuronal and glial processes in tumor cells to promote glioblastoma growth.

Neuro-oncology·2026
Same author

Tumor Growth Rate (TGR) Analysis Predicts Survival in a Multicenter Phase II Study of the PARP Inhibitor Pamiparib (BGB-290) with Temozolomide in Recurrent IDH-Mutant Gliomas (ABTC-1801).

AJNR. American journal of neuroradiology·2026
Same author

Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Erratum: Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Isolated Cranial Tremors: A Reappraisal.

Seminars in neurology·2026
Same journal

Dystonia and Tremor.

Seminars in neurology·2026
Same journal

Pendular nystagmus and oculopalatal tremor.

Seminars in neurology·2026
Same journal

Sanjay Pandey, MBBS, MD, DNB, DM, FIAN, and Aasef Shaikh, MD, PhD.

Seminars in neurology·2026
Same journal

Tremor.

Seminars in neurology·2026
Same journal

Carotid Disease.

Seminars in neurology·2026
See all related articles

Early detection of metastatic epidural spinal cord compression is crucial for cancer patient recovery. Prompt diagnosis and intervention improve the chances of regaining function and relieving pain.

Area of Science:

  • Oncology
  • Neurology
  • Radiology

Background:

  • Improving cancer survival rates necessitate focus on early detection of complications.
  • Metastatic epidural spinal cord compression (MESCC) is a common oncologic emergency.
  • The epidural space is the most frequent site for spinal cord metastasis.

Purpose of the Study:

  • To review the epidemiology, anatomy, pathophysiology, and clinical presentation of MESCC.
  • To discuss diagnostic evaluation and treatment modalities for MESCC.
  • To outline prognostic factors and management strategies for MESCC.

Main Methods:

  • Literature review of epidemiology, anatomy, and pathophysiology of MESCC.
  • Analysis of clinical presentation and diagnostic approaches.

Related Experiment Videos

  • Evaluation of treatment options based on patient-specific factors.
  • Main Results:

    • MESCC requires prompt diagnosis and intervention for functional recovery.
    • Management strategies aim to preserve or restore spinal cord function and alleviate pain.
    • Treatment decisions are individualized based on disease burden, life expectancy, and patient values.

    Conclusions:

    • Early detection and timely intervention are key to managing MESCC.
    • A multidisciplinary approach is essential for optimal patient outcomes.
    • Personalized treatment plans improve quality of life for cancer patients with spinal cord compression.